Crossovers in coronary artery bypass grafting trials: desirable, undesirable, or both?
暂无分享，去创建一个
[1] B. Levin,et al. Effect of crossover on the statistical power of randomized studies. , 1989, The Annals of thoracic surgery.
[2] E. Varnauskas. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. , 1988, The New England journal of medicine.
[3] E. Passamani,et al. Survival following coronary artery bypass grafting in patients with severe angina pectoris (CASS). An observational study. , 1985, The Journal of thoracic and cardiovascular surgery.
[4] Cass Principal Investigators and Their Associates. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Comparability of entry characteristics and survival in randomized patients and nonrandomized patients meeting randomization criteria. , 1984, Journal of the American College of Cardiology.
[5] L. Wilkins. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups. , 1983, Circulation.
[6] Lippincott Williams Wilkins,et al. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. , 1983, Circulation.
[7] D. Richards,et al. The lungs as receptor sites for cardiovascular regulation. , 1981, Circulation.